首页> 外文OA文献 >Penicillins, cephalosporins, and tetracyclines in treatment of hamsters with fatal leptospirosis.
【2h】

Penicillins, cephalosporins, and tetracyclines in treatment of hamsters with fatal leptospirosis.

机译:青霉素,头孢菌素和四环素类药物可治疗致命性钩端螺旋体病的仓鼠。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A predictable 6- to 7-day course of a fatal Leptospira interrogans serovar bataviae infection in experimentally infected mature 110- to 150-g hamsters was used to evaluate the therapeutic efficacy of conventionally used and newer antibiotics. Active drugs were ampicillin, bacampicillin, cyclacillin, piperacillin, mezlocillin, doxycycline, chlortetracycline, cefotaxime, and moxalactam. Cephalexin, cefadroxil, cefamandole, and cefoperazone showed little or no activity in preliminary studies. In delayed treatment studies, all nine active drugs prevented death of hamsters even when treatment was delayed until 1 to 2.5 days before expected time of death. Leptospires in kidneys of surviving animals could be demonstrated in one or more hamsters treated with doxycycline, chlortetracycline, cyclacillin, and piperacillin, but in none of the animals treated with ampicillin, bacampicillin, mezlocillin, cefotaxime, and moxalactam. The potential usefulness of newer penicillins and cephalosporins, as well as ampicillin, chlortetracycline, and doxycycline, for treatment of severe leptospirosis is reported.
机译:在实验感染的成熟的110至150 g仓鼠中,可预测的致命性钩端螺旋体血清型bataviae感染的6至7天病程可用于评估常规使用的和较新的抗生素的治疗效果。活性药物是氨苄西林,巴坎西林,环西林,哌拉西林,美洛西林,强力霉素,金霉素,头孢噻肟和莫拉西坦。在初步研究中,头孢氨苄,头孢氨苄,头孢曼多尔和头孢哌酮显示很少或没有活性。在延迟治疗研究中,即使将治疗延迟到预期死亡时间之前1至2.5天,所有9种活性药物仍可防止仓鼠死亡。在用强力霉素,金霉素,环菌素和哌拉西林治疗的一种或多种仓鼠中,可以证明存活动物肾脏中的钩端螺旋体,但在用氨苄西林,巴坎西林,美洛西林,头孢噻肟和莫拉西坦治疗的动物中均未见。据报道,较新的青霉素和头孢菌素以及氨苄西林,金霉素和强力霉素对重度钩端螺旋体病的治疗具有潜在的作用。

著录项

  • 作者

    Alexander, A D; Rule, P L;

  • 作者单位
  • 年度 1986
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号